Personalized vaccine tested to control HIV without daily pills
NCT ID NCT00510497
Summary
This early-phase study tested a personalized vaccine made from a patient's own immune cells and inactivated HIV. The goal was to see if it was safe and could help control the virus after participants temporarily stopped their standard antiretroviral medication. Eleven people with HIV who had not yet started medication participated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.